Hazel Tau & others v. GlaxoSmithKline, Boehringer Ingelheim & others, 2002 (South African Competition Commission, Competition Commission Case No. 2002Sep226)
The Hazel Tau case provides an example of how competition law can be used to facilitate access to affordable medicines.
Case Summary